- Journal of American Medical Association (JAMA)

References for Health Behaviors Related to COVID-19 Drug Treatment by Journal/Source

Trends in mean weekly prescriptions dispensed between February 16 and April 25, 2020 for hydroxychloroquine/chloroquine, azithromycin, and the top 10 drugs of 2019 were analyzed. 

During the week of March 15-March 21, prescription fills for hydroxychloroquine/chloroquine increased compared to 2019:
+ 1,977.0% for <28 tablet fills
+179.0% for 28-60 tablet fills
+ 182.1% for >60 tablet fills

In total, there were 483,425 excess prescription fills of hydroxychloroquine/chloroquine during the 10-week period in 2020 compared with 2019..

Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States

The sensationalizing of certain medications as treatment for COVID-19 in the media and by prominent public figures despite lack of scientific support has led to a range of public responses. 

University of Michigan - Ann Arbor

- use of existing drugs to mitigate COVID-19
- health behaviors related to COVID-19 drug treatment

Effective COVID-19 Drug Targets and Candidates

- Amlodipine
- Apilimod
- Arbidol + lopinavir/ritonavir 
- Azithromycin
- Azithromycin+Hydroxychloroquine
- Camostat mesylate
- Chloroquine
- Chloroquine + macrolide (Azithromycin or clarithromycin)
- Clofazimine
- Colchicine
- Corticosteroids 
- Diltiazem
- Dexamethasone
- Famotidine
- Favipiravir
- Felodipine 
- Heparin
- Hydroxychloroquine
- Interferon-α2b 
- Lopinavir-Ritonavir
- Nifedipine
- Nitazoxanide
- Oseltamivir
- Propolis
- Rapamycin
- Remdesivir
- Ribavirin
- Tocilizumab
- Verapamil
- Statin
-Tofacitinib

Learn Before

Related

Learn After